Wang, Binghe

Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics

Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry

Cancer, Hypoxia, and MetabolismHeterocyclic Compound Synthesis and Bioactivity

Cited by 140

Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor

Zhao, J., Du, Y., Horton, J. R., Upadhyay, A. K., Lou, B., Bai, Y., Zhang, X., Du, L., Li, M., Wang, B., et al. (2011) · Proceedings of the National Academy of Sciences

14-3-3 protein interactionsProtein Kinase Regulation and GTPase Signaling

Cited by 105

Fluorescein analogues inhibit SecA ATPase: the first sub-micromolar inhibitor of bacterial protein translocation.

Huang, Y., Wang, H., Gao, F., Li, M., Yang, H., Wang, B., & Tai, P. C. (2012) · ChemMedChem

Bacterial Genetics and BiotechnologyATP Synthase and ATPases Research

Cited by 42

Design, syntheses and evaluation of 4-oxo-5-cyano thiouracils as SecA inhibitors.

Chaudhary, A. S., Jin, J., Chen, W., Tai, P. C., & Wang, B. (2015) · Bioorganic & Medicinal Chemistry

Synthesis and Characterization of Heterocyclic CompoundsBacterial Genetics and Biotechnology

Cited by 31